glp-1 long-term effects Of GLP-1s: Risks & Benefits – Forbes Health How GLP-1 Medications Boost Weight

When Medicare begins covering GLP-1s in April, Schott believes Lilly will gain the most, with 4.5 million Medicare patients projected to use the drugs by 2030

, 2024 obesity Algorithm E-book, Obes Med Assoc

This summer, wanting to shed fat and gain muscle, he sought out retatrutide, a next-generation GLP-1, glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptor agonista triple agonist targeting appetite, blood sugar, and metabolism

Comorbidities : Patients with certain conditions, such as cardiovascular disease, may benefit more from these medications, making them more likely to be considered for treatment

Published January 23, 2024